CVS Health's first quarter 2026 results beat estimates with revenue up 6.2%, leading to raised full-year guidance.

CVS Health reported first quarter 2026 revenues of $100.4 billion, a 6.2% year-over-year increase, and an Adjusted EPS of $2.57. The strong performance prompted the company to raise its full-year guidance for both Adjusted EPS and cash flow from operations.

Key Highlights

• First quarter revenue of $100.4 billion and Adjusted EPS of $2.57 both surpassed analyst expectations.
• The company raised its full-year 2026 Adjusted EPS guidance to a range of $7.30 to $7.50, up from the prior range of $7.00 to $7.20.
• The Medical Benefit Ratio (MBR) improved to 84.6% from 87.3% a year ago, driven by better performance in the Government business and indicating progress on margin recovery.